About the 10 x '20 Initiative
Patients are dying from drug-resistant infections that used to be treatable. Though new antibiotics are desperately needed, pharmaceutical companies are withdrawing from the antibiotics market because of the low return on investment and the difficult regulatory environment. The 10 x '20 Initiative is a global effort to foster development of 10 innovative antibiotics by 2020, sponsored by the Infectious Diseases Society of America.
Learn about the 10 x '20 initiative>>